UKHSA In silico modelling of the Nucleocapsid protein of SARS-CoV-2

View buyer

Estimated value

£400k

services

Awarded value

Suppliers

0

Lots

1

0 awarded

Published

23 Sept 2022

This is a preliminary market engagement notice

Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.

Run market simulation

Description

Market Engagement for in silico analysis of the impact of mutations of the Nucleocapsid protein of SARS-CoV-2 on lateral flow device sensitivity.

Scope

Reference
ocds-h6vhtk-036b0a
Total value
£400,000 excluding VAT
Commercial tool
Standalone contract
Main category
services
Contract locations
UK